Form 4: Walgreens Boots Alliance Sells Additional Cencora Shares

Walgreens Boots Alliance continues to reduce its stake in Cencora, selling a significant block of shares through both open market and private transactions.

Summary

• Walgreens Boots Alliance, Inc. (WBA) has filed a Form 4 detailing changes in its beneficial ownership of Cencora, Inc. (COR) stock.
• On August 1, 2024, WBA sold 4,438,171 shares of Cencora common stock at a price of $240.56 per share.
• The sale was executed by Walgreens Boots Alliance Holdings LLC (WBA Holdings), an indirect wholly-owned subsidiary of WBA.
• The transaction included a sale of 3,398,929 shares pursuant to Rule 144 and a sale of 1,039,242 shares in a private transaction to Cencora.
• Following the reported transaction, WBA's indirect beneficial ownership of Cencora shares stands at 19,980,000 shares.
• These shares are held by WBA Holdings, with WBA Investments, Inc. also potentially deemed to have beneficial ownership.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it primarily reports a transaction. The continued sale of shares could be viewed as slightly negative, but it's part of a previously disclosed plan.

Future Outlook

The document does not contain specific forward-looking statements, but the continued reduction of Walgreens Boots Alliance's stake in Cencora suggests a strategic shift in their investment portfolio.

Industry Context

Walgreens Boots Alliance's ongoing divestiture of Cencora shares reflects a broader trend of companies streamlining their operations and focusing on core business areas. This move could be aimed at generating capital for other strategic initiatives or reducing debt.

Comparison to Industry Standards

• Comparing Walgreens Boots Alliance's divestiture strategy to similar moves by other large pharmaceutical or retail companies, such as CVS Health's acquisition of Aetna, reveals a common theme of strategic realignment.
• The sale of Cencora shares can be benchmarked against other large block trades in the healthcare distribution sector to assess the impact on market liquidity and valuation.
• Similar transactions, such as McKesson's strategic review of its business segments, highlight the industry's focus on optimizing capital allocation and enhancing shareholder value.

Stakeholder Impact

• The sale of shares could potentially impact Cencora's stock price and investor sentiment.
• Walgreens Boots Alliance's shareholders may benefit from the capital generated through the sale.

Key Dates